Skip to main content
. Author manuscript; available in PMC: 2011 Apr 14.
Published in final edited form as: Immunol Rev. 2005 Aug;206:232–259. doi: 10.1111/j.0105-2896.2005.00280.x

Table 2. Animal models treated by oral (nasal) anti-CD3.

Experimental autoimmune encephalomyelitis (SJL, NOD)
Streptozocin induced autoimmune diabetes (AKR)
Autoimmune diabetes in the NOD mouse (NOD)
Collagen-induced arthritis (DBA1)
Type II diabetes (Ob/Ob mouse)
Lupus (NZB)
Atherosclerosis (ApoE -/- mice)